Arkolith/Insider Trading/TNXP/Form 4

Taylor Carolyn E.

DirectorTonix Pharmaceuticals Holding Corp. (TNXP) · full profile →Form 4 · filed Aug 21, 2025
Net Buying
Open-Market Buys
$15K
Open-Market Sells
$0
Net Open-Market Flow
$15K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 21, 2025Buy(P)418$36.03$15K418

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001999371-25-011836) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML